GUIDED THERAPEUTICS INC - FORM 8-K - January 13, 2011

Attached files

file filename
EX-99.1.9 - PRESENTATION - GUIDED THERAPEUTICS INCslide9.htm
EX-99.1 - PRESENTATION - GUIDED THERAPEUTICS INCslide1.htm
EX-99.1.2 - PRESENTATION - GUIDED THERAPEUTICS INCslide2.htm
EX-99.1.4 - PRESENTATION - GUIDED THERAPEUTICS INCslide4.htm
EX-99.1.6 - PRESENTATION - GUIDED THERAPEUTICS INCslide6.htm
EX-99.1.7 - PRESENTATION - GUIDED THERAPEUTICS INCslide7.htm
EX-99.1.5 - PRESENTATION - GUIDED THERAPEUTICS INCslide5.htm
EX-99.1.3 - PRESENTATION - GUIDED THERAPEUTICS INCslide3.htm
EX-99.1.8 - PRESENTATION - GUIDED THERAPEUTICS INCslide8.htm
EX-99.1.10 - PRESENTATION - GUIDED THERAPEUTICS INCslide10.htm
EX-99.1.17 - PRESENTATION - GUIDED THERAPEUTICS INCslide17.htm
EX-99.1.11 - PRESENTATION - GUIDED THERAPEUTICS INCslide11.htm
EX-99.1.12 - PRESENTATION - GUIDED THERAPEUTICS INCslide12.htm
EX-99.1.21 - PRESENTATION - GUIDED THERAPEUTICS INCslide21.htm
EX-99.1.19 - PRESENTATION - GUIDED THERAPEUTICS INCslide19.htm
EX-21.1.20 - PRESENTATION - GUIDED THERAPEUTICS INCslide20.htm
EX-99.1.14 - PRESENTATION - GUIDED THERAPEUTICS INCslide14.htm
EX-99.1.13 - PRESENTATION - GUIDED THERAPEUTICS INCslide13.htm
EX-99.1.18 - PRESENTATION - GUIDED THERAPEUTICS INCslide18.htm
EX-99.1.15 - PRESENTATION - GUIDED THERAPEUTICS INCslide15.htm
EX-99.1.16 - PRESENTATION - GUIDED THERAPEUTICS INCslide16.htm
 
 
SECURITIES AND EXCHANGE COMMISSION
 
 
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
 
 
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (January 10, 2011):  January 13, 2011
 
GUIDED THERAPEUTICS, INC.
 (Exact Name of Registrant as Specified in Its Charter)
 
         
Delaware
(State or Other Jurisdiction of Incorporation)
  
0-22179
(Commission File Number)
  
58-2029543
(IRS Employer Identification No.)

   
5835 Peachtree Corners East, Suite D
Norcross, Georgia
(Address of Principal Executive Offices)
30092
(Zip Code)
 
Registrant's Telephone Number, Including Area Code:     (770) 242-8723
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions :
 
 
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
 
 
 
 
 
 
 
 
 

 
Section 7.01  (Regulation FD Disclosure)
 
On January 10, 2011 Guided Therapeutics made a presentation to the Sidoti Micro Cap conference, a copy of which is furnished as exhibit 99.1 hereto and which information is incorporated herein by reference.
 
Item 9.01  Financial Statements and Exhibits

The following exhibit is furnished with this report:
 
 Exhibit No.     Description
99.1  Presentation
 

 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
     GUIDED THERAPEUTICS, INC  
       
   By:  /s/ MARK L. FAUPEL  
                                                                                                                                                                                                                  Mark L. Faupel, Ph.D.  
     CEO & President  
 Date:  January 13, 2011      
 
 
 
 
 
 
 
 
 
2
 
 

GUIDED THERAPEUTICS INC Reports